Core Laboratories Inc. logo

Core Laboratories Inc. (CLB)

Market Closed
20 Jul, 20:00
NYSE NYSE
$
11. 19
-0.15
-1.3228%
$
523.66M Market Cap
34.08 P/E Ratio
0.04% Div Yield
635,107 Volume
0.87 Eps
$ 11.34
Previous Close
Add Transaction
Day Range
11.02 11.4
Year Range
9.72 20.36
Want to track CLB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Core Laboratories Inc. (CLB) Q3 2024 Earnings Call Transcript

Core Laboratories Inc. (CLB) Q3 2024 Earnings Call Transcript

Core Laboratories Inc. (NYSE:CLB ) Q3 2024 Earnings Conference Call October 24, 2024 8:30 AM ET Company Participants Larry Bruno - Chairman and Chief Executive Officer Chris Hill - Chief Financial Officer Gwen Gresham - Senior Vice President and Head, Investor Relations Conference Call Participants Sean Mitchell - Daniel Energy Partners Stephen Gengaro - Stifel Operator Good day and welcome to the Core Lab Q3 2024 Earnings Conference Call. All participants will be in a listen-only mode.

Seekingalpha | 1 year ago
Core Laboratories' Q3 Earnings and Sales Beat Estimates

Core Laboratories' Q3 Earnings and Sales Beat Estimates

CLB expects Reservoir Description revenues of $87.5-$90.5 million and Production Enhancement revenues of $41-$45 million for the fourth quarter of 2024.

Zacks | 1 year ago
Core Laboratories (CLB) Q3 Earnings Match Estimates

Core Laboratories (CLB) Q3 Earnings Match Estimates

Core Laboratories (CLB) came out with quarterly earnings of $0.25 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.22 per share a year ago.

Zacks | 1 year ago
Energy Stocks to Watch Amid Q3 Earnings Despite Pricing Pressures

Energy Stocks to Watch Amid Q3 Earnings Despite Pricing Pressures

Energy stocks such as PUMP, CLB and OII are poised to deliver a Q3 earnings beat.

Zacks | 1 year ago
What's in Store for Core Laboratories Stock in Q3 Earnings?

What's in Store for Core Laboratories Stock in Q3 Earnings?

CLB is expected to report higher revenues compared with the previous quarter, along with reduced costs for services and product sales and general administrative expenses.

Zacks | 1 year ago
Can Core Laboratories (CLB) Keep the Earnings Surprise Streak Alive?

Can Core Laboratories (CLB) Keep the Earnings Surprise Streak Alive?

Core Laboratories (CLB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks | 1 year ago
Core Laboratories (CLB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Core Laboratories (CLB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Core Laboratories (CLB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 1 year ago
Here's Why Core Laboratories (CLB) is a Strong Value Stock

Here's Why Core Laboratories (CLB) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 1 year ago
Is Now the Right Time to Buy Core Laboratories After Its 14% YTD Rise?

Is Now the Right Time to Buy Core Laboratories After Its 14% YTD Rise?

CLB is a compelling investment in the oilfield services sector, featuring strong fundamentals, innovative technologies and a disciplined financial strategy poised for growth.

Zacks | 1 year ago
OPEC's Forecast of Peak Oil Demand: A Long Horizon Ahead

OPEC's Forecast of Peak Oil Demand: A Long Horizon Ahead

Considering OPEC's optimistic oil demand growth forecast, we recommend buying stocks like CLB, FTI and TUWOY.

Zacks | 1 year ago
Are Oils-Energy Stocks Lagging CORE LABS INC (CLB) This Year?

Are Oils-Energy Stocks Lagging CORE LABS INC (CLB) This Year?

Here is how Core Laboratories (CLB) and Talen Energy Corporation (TLN) have performed compared to their sector so far this year.

Zacks | 1 year ago
Core Laboratories (CLB) Loses -10.14% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Core Laboratories (CLB) Loses -10.14% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Core Laboratories (CLB) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Zacks | 1 year ago
Loading...
Load More